Midatech Pharma plc MTP
Day range unavailable
52-week range unavailable
- Market cap
- 1.98M
- Revenue (ttm)
- 645.00K
- Shares out
- 6.93M
- Beta
- 1.22
Key statistics
- Enterprise value
- -5.25M
- PEG ratio
- 0.00
- Price / sales
- 3.06
- Price / book
- 0.04
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 16.70%
- Free cash flow
- -6.02M
- Total cash
- 6.42M
- Total debt
- 713.00K
- Return on equity
- -95.47%
- Short % of float
- 0.00%
- 50-day average
- 1.50
- 200-day average
- 6.83
Next earnings
Consensus EPS estimate 0.00.
About Midatech Pharma plc
Biodexa Pharmaceuticals Plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United Kingdom
- Website
- midatechpharma.com
News
Pecoy Copper Defines Large Untested MTP-01 Target Beyond Newly Expanded Northwest Copper Mineralization 
MTP Joins Real, Launches Midwest Top Producers Brand 
Italy's banking shake-up: all the M&A deals since 2025 
Why Is Midatech Pharma (BDRX) Stock Up 64% Today? 
Stocks That Hit 52-Week Lows On Friday 
Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session 
Midatech Pharma plc continues to plummet on news of London delisting 
Stocks That Hit 52-Week Lows On Monday 
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday - Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
Your note
Sign in to keep a note on MTP — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| Armistice Capital LLC | — | Sold | May 28, 2020 | 36,118 |
| Bank of America Corporation | — | Decrease | Jul 29, 2020 | 4,810 |
| Goldman Sachs Group, Inc. | — | Holding | Aug 5, 2020 | 1,500 |
| L1 Global Manager Pty, Ltd. | — | Sold | May 18, 2020 | 25,181 |
| Lind Partners, L.L.C. | — | Sold | May 25, 2020 | 60,040 |
| Lombard Odier Asset Management (Europe) Ltd | — | Holding | Jul 5, 2021 | 295,500 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Armistice Capital, LLC | 0.00% | 96,707 | 27.57K | Dec 30, 2022 |
| Renaissance Technologies, LLC | 0.00% | 8,867 | 2.53K | Dec 30, 2022 |
| Morgan Stanley | 0.00% | 3,924 | 1.12K | Dec 30, 2022 |
| Money Concepts Capital Corporation | 0.00% | 69 | 19 | Dec 30, 2022 |
| UBS Group AG | 0.00% | 31 | 8 | Dec 30, 2022 |
| Group One Trading, L.P. | 0.00% | 1 | 0 | Dec 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.01% | 1,479 | 421 | Nov 29, 2022 |